FDA grants full approval to another COVID-19 vaccine | News


The U.S. Food and Drug Administration (FDA) recently granted full approval to a second COVID-19 vaccine.

Many San Bernardino County residents already know this vaccine as the Moderna COVID-19 vaccine, but now that it has full approval, the vaccine will be marketed as Spikevax for everyone 18 years and older, the county said in a news release on Feb. 4.

Moderna’s Spikevax vaccine initially became available under emergency use authorization back on Dec. 18, 2020.

Since then, more than half a million Moderna vaccines have been received in San Bernardino County. The FDA’s first full approval of a COVID-19 vaccine came in August with Pfizer’s Comirnaty vaccine.

“The FDA’s approval of Spikevax is a significant step in the fight against the COVID-19 pandemic, marking the second vaccine approved to prevent COVID-19. The public can be assured that Spikevax meets the FDA’s high standards for safety, effectiveness and manufacturing quality required of any vaccine approved for use in the United States,” said Acting FDA Commissioner Janet Woodcock, M.D. “While hundreds of millions of doses of Moderna COVID-19 vaccine have been administered to individuals under emergency use authorization, we understand that for some individuals, FDA approval of this vaccine may instill additional confidence in making the decision to get vaccinated.”

So far, more than 65 percent of San Bernardino County residents ages 5 and older have received at least one dose of a COVID-19 vaccine. Persons who are still unvaccinated or need another dose or booster are urged to visit myturn.ca.gov or vaccines.gov.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *